Castrillo R*, P. Comprehensive Insights into ModRNA Vaccines: Persistent PP-Spike Recombinant Protein, Hyperimmune/Inflammatory Reactions, Thrombotic Vasculopathy, Chronic Organ Complications and Excess Deaths. Annals of Immunology & Immunotherapy 2024, 6, doi:10.23880/aii-16000181.
Castrillo R*, P. Comprehensive Insights into ModRNA Vaccines: Persistent PP-Spike Recombinant Protein, Hyperimmune/Inflammatory Reactions, Thrombotic Vasculopathy, Chronic Organ Complications and Excess Deaths. Annals of Immunology & Immunotherapy 2024, 6, doi:10.23880/aii-16000181.
Castrillo R*, P. Comprehensive Insights into ModRNA Vaccines: Persistent PP-Spike Recombinant Protein, Hyperimmune/Inflammatory Reactions, Thrombotic Vasculopathy, Chronic Organ Complications and Excess Deaths. Annals of Immunology & Immunotherapy 2024, 6, doi:10.23880/aii-16000181.
Castrillo R*, P. Comprehensive Insights into ModRNA Vaccines: Persistent PP-Spike Recombinant Protein, Hyperimmune/Inflammatory Reactions, Thrombotic Vasculopathy, Chronic Organ Complications and Excess Deaths. Annals of Immunology & Immunotherapy 2024, 6, doi:10.23880/aii-16000181.
Abstract
A recent study revealed a persistent presence of the PP-Spike recombinant protein in 50% of individuals who received ModRNA injections, contrasting with unvaccinated controls, whether SARSCoV-2 infected or not, up to 187 days post-injection. The implications of these findings are discussed in the context of PP-Spike recombinant protein-induced hyperimmune/inflammatory reactions and thrombotic vasculitis as mechanisms to elucidate the serious side effects, long-term organ complications, and excess deaths observed after administering Covid ModRNA products. These results underscore the urgent need for a comprehensive reassessment of the risk-benefit profile of ModRNA injections, including an immediate halt in their use for any person, and a renewed emphasis on understanding and addressing their long-term effects on human health
Biology and Life Sciences, Immunology and Microbiology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
